3D Printed Plastics Could Replace Metallic Collimators
By MedImaging International staff writers Posted on 18 Nov 2019 |
Image: Plastic collimator samples made using 3D printing (Photo courtesy of TPU)
3D printing of plastic collimators for external beam radiation therapy (EBRT) could improve accuracy and reduce dose delivery and collimator manufacturing time, claims a new study.
In order to develop the plastic collimators, researchers at Tomsk Polytechnic University (TPU; Russia), Moscow City Oncology Hospital No. 62 (Russia), and University Hospital Hamburg-Eppendorf (UKE; Germany) first used a numerical model to study the capability of high impact polystyrene (HIS) and acrylonitrile butadiene styrene (ABS) plastics to absorb an electron beam, and the required thickness and manufacturing method needed for the printed collimator to completely absorb the EBRT dose.
They then used the plastics to manufacture the first products through the method of layer-by-layer fused deposition modeling, using rapid prototyping. As the manufacturing process can affect crucial properties, such as material homogeneity (due to the presence of residual air-filled cavities), Monte Carlo simulations were used to determine electron depth dose distribution. The appropriate thickness for total absorption of 6 MeV electron beams was found tobe at least 4 cm, at least 8 cm for 12 MeV, and 11 cm for 20 MeV. The study was published in the August 2019 issue of Physica Medica.
“Metal collimators should be 1.6 cm thick to absorb the beam but, unlike metal, plastic does not have the same density and a number of other characteristics. We conducted a number of calculations and experiments to determine the thickness of a plastic product,” said senior author Sergei Stuchebrov, PhD, of the TPU Research School of High-Energy Physics. “For instance, we used special dosimeters, placed inside the plastic, to measure the depth distribution of the electron beam. The results can be used to further develop 3D printing procedures for medical electron beam profile formation.”
Collimators allow radiotherapy treatment (RT) flexibility in shielding organs-at-risk (OAR), while ensuring that the prescribed dose is delivered to the target. While in linear RT, a multi-leaf collimator (MLC) can be used to align the treatment field parallel to the radiation field and to the shape of the tumor, EBRT works from multiple directions, requiring fabrication of a patient-specific collimator using hand-crafted blocks.
Related Links:
Tomsk Polytechnic University
Moscow City Oncology Hospital No. 62
University Hospital Hamburg-Eppendorf
In order to develop the plastic collimators, researchers at Tomsk Polytechnic University (TPU; Russia), Moscow City Oncology Hospital No. 62 (Russia), and University Hospital Hamburg-Eppendorf (UKE; Germany) first used a numerical model to study the capability of high impact polystyrene (HIS) and acrylonitrile butadiene styrene (ABS) plastics to absorb an electron beam, and the required thickness and manufacturing method needed for the printed collimator to completely absorb the EBRT dose.
They then used the plastics to manufacture the first products through the method of layer-by-layer fused deposition modeling, using rapid prototyping. As the manufacturing process can affect crucial properties, such as material homogeneity (due to the presence of residual air-filled cavities), Monte Carlo simulations were used to determine electron depth dose distribution. The appropriate thickness for total absorption of 6 MeV electron beams was found tobe at least 4 cm, at least 8 cm for 12 MeV, and 11 cm for 20 MeV. The study was published in the August 2019 issue of Physica Medica.
“Metal collimators should be 1.6 cm thick to absorb the beam but, unlike metal, plastic does not have the same density and a number of other characteristics. We conducted a number of calculations and experiments to determine the thickness of a plastic product,” said senior author Sergei Stuchebrov, PhD, of the TPU Research School of High-Energy Physics. “For instance, we used special dosimeters, placed inside the plastic, to measure the depth distribution of the electron beam. The results can be used to further develop 3D printing procedures for medical electron beam profile formation.”
Collimators allow radiotherapy treatment (RT) flexibility in shielding organs-at-risk (OAR), while ensuring that the prescribed dose is delivered to the target. While in linear RT, a multi-leaf collimator (MLC) can be used to align the treatment field parallel to the radiation field and to the shape of the tumor, EBRT works from multiple directions, requiring fabrication of a patient-specific collimator using hand-crafted blocks.
Related Links:
Tomsk Polytechnic University
Moscow City Oncology Hospital No. 62
University Hospital Hamburg-Eppendorf
Latest Nuclear Medicine News
- New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure
- New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
- New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
- AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
- Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times
- New Method for Triggering and Imaging Seizures to Help Guide Epilepsy Surgery
- Radioguided Surgery Accurately Detects and Removes Metastatic Lymph Nodes in Prostate Cancer Patients
- New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
- Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer
- Targeted Therapy Delivers Radiation Directly To Cells in Hard-To-Treat Cancers
- New PET Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Algorithm Predicts Prostate Cancer Recurrence in Patients Treated by Radiation Therapy
- Novel PET Imaging Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Ultrafast Laser Technology to Improve Cancer Treatment
- Low-Dose Radiation Therapy Demonstrates Potential for Treatment of Heart Failure
- New PET Radiotracer Aids Early, Noninvasive Detection of Inflammatory Bowel Disease